Browse Drug Recalls
3,430 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 3,430 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 3,430 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 22, 2015 | Clarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist. By: Wockhardt... | cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wo... | Class II | Blenheim Pharmacal, Inc. |
| May 12, 2015 | Famotidine Tablets, USP, 20 mg Tablets, Over the Counter, Made in India and l... | CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer c... | Class II | Allegiant Health |
| Apr 29, 2015 | Azithromycin Tablets, USP, 250 mg, Rx Only, packaged in a) 2 count and b) 4 c... | cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm... | Class II | PD-Rx Pharmaceuticals, Inc. |
| Apr 29, 2015 | Azithromycin 500 mg tablets, Rx Only, packaged in a) 1 count, b) 2 count, c) ... | cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm... | Class II | PD-Rx Pharmaceuticals, Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 20 mg Tablets, Packaged in A) 30 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Clarithromycin Tablets, USP, 500 mg Tablets, 60 Count Bottles, Rx Only. Manuf... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 40 mg Tablets, Packaged in A) 30 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 50 mg Tablets, Packaged i... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Zolpidem Tartrate Tablets, 10 mg Tablets, CIV, Packaged in A) 100 Count Bott... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 40 mg Tablets, Packaged in A) 100 Count Bottles (NDC:... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Amlodipine Besylate Tablets, 10 mg Tablets, Packaged as A) 90 Count Bottles... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 20 mg Tablets, Packaged in A) 100 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Amlodipine Besylate Tablets, 2.5 mg Tablets, Packaged in 90 Count Bottles, Rx... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Azithromycin Tablets, USP, 500 mg Tablets, Packaged in A) 30 Count Bottles (N... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Extended Phenytoin Sodium Capsules, USP, 100 mg Capsules, Packaged as A) 100 ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Tamsulosin Hydrochloride Capsules, USP*, 0.4 mg Capsules, Packaged in A) 100 ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lamotrigine Extended-Release Tablets, 25 mg Tablets, 30 Count Bottles, Rx Onl... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Azithromycin Tablets, USP, 250 mg Tablets, Packaged in A) 30 Count Bottles (N... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 2.5 mg Tablets, Packaged in A) 100 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 25 mg Tablets, Packaged i... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 200 mg Tablets, Packaged ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Captopril Tablets, USP, 25 mg Tablets, Packaged in A) 100 Count Bottles (NDC:... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Zonisamide Capsules, 50 mg Capsules, Packaged in 100 Count Bottles, Rx Only. ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lansoprazole Delayed-Release Capsules, USP, 15 mg Capsules, For Repackaging O... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Azithromycin Tablets, USP, 600 mg Tablets, Packaged in 30 Count Bottles, Rx o... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 5 mg Tablets,Packaged in A) 100 Count Bottles (NDC: 6... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lansoprazole Delayed-Release Capsules, USP, 15 mg Capsules, Packaged in 30 Co... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Zolpidem Tartrate Tablets, 5 mg Tablets, CIV, Packaged in 100 Tablet Bottles,... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Captopril Tablets, USP, 100 mg Tablets, Packaged in 100 Count Bottles, Rx onl... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lansoprazole Delayed-Release Capsules, USP, 30 mg Capsules, Packaged in A) 30... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Zonisamide Capsules, 25 mg Capsules, Packaged in 100 Count Bottles, Rx Only. ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Amlodipine Besylate Tablets, 5 mg Tablets, Packaged as A) 90 Count Bottles (N... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Zonisamide Capsules, 100 mg Capsules, Packaged in 100 Count Bottles, Rx Only.... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Captopril Tablets, USP, 50 mg Tablets, Packaged in A) 100 Count Bottles (NDC:... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 100 mg Tablets, Packaged ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 30 mg Tablets, Packaged in A) 100 Count Bottles (ND... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 10 mg Tablets, For Repacking Only, Packaged in 50,00... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 10 mg Tablets, Packaged in A) 100 Count Bottles (NDC:... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Feb 12, 2015 | Bromfenac Ophthalmic Solution 0.09%, Rx Only. Mfg For: Apotex Corp., Weston, ... | CGMP Deviations: Product excipient was not re-tested at the appropriate date. | Class III | Apotex Inc. |
| Dec 4, 2014 | Eye Drops A.C. (Tetrahydrozoline HCl 0.05%, Zinc sulfate 0.25%), 0.5 FL OZ (1... | CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-... | Class III | K C Pharmaceuticals Inc |
| Dec 4, 2014 | Eye Drops Advanced Relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povid... | CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-... | Class III | K C Pharmaceuticals Inc |
| Dec 4, 2014 | Eye Drops (Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the C... | CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-... | Class III | K C Pharmaceuticals Inc |
| Dec 4, 2014 | Eye Drops Industrial Strength (Polyethylene glycol 400 1%, Tetrahydrozoline H... | CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-... | Class III | K C Pharmaceuticals Inc |
| Oct 20, 2014 | Z-COTE HP 1 TRANSPARENT ZINC OXIDE, Zinc Oxide (and) Triethoxycaprylylsilane,... | cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lo... | Class III | Nanophase Technologies Corporation |
| Sep 22, 2014 | CEPHALEXIN MONOHYDRATE CAPSULES,USP, 500 mg, 20-count bottle, Rx only, Manufa... | CGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not ... | Class II | Physicians Total Care, Inc. |
| Aug 13, 2014 | PROPRANOLOL HYDROCHLORIDE INJECTION, USP 1 mg/mL, 1 mL Single Dose Vial, Rx o... | CGMP Deviations: Citations given to API supplier by the Italian Health Agency AIFA for several cr... | Class II | Fresenius Kabi USA, LLC |
| Jul 18, 2014 | Tetrahydrozoline Hydrochloride, USP, 1 KG Bottle. Spectrum Chemical MFG CORP... | CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy. | Class II | Spectrum Laboratory Products |
| Jul 17, 2014 | Tetrahydrozoline HCL, 16 kg drum. Societa Italiana Medicinali Scandicci (S.I... | CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy. | Class II | SST Corporation |
| Jul 9, 2014 | Clonidine Base Micronized, 55.8 Kg, Rx Only, S.I.M.S. , Chemical Product for ... | cGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients m... | Class II | Gyma Laboratories Of Amer,Inc |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.